Article Information
History
- September 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zhuoran Xu1,3,
- Akanksha Verma2,
- Uska Naveed1,
- Samuel Bakhoum2,4,5,
- Pegah Khosravi1,6 and
- Olivier Elemento1,2,*
- 1Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, USA
- 2Volastra Therapeutics, New York, USA
- 3Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA
- 4Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA
- 5Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA
- 6Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
- ↵*Corresponding author; email: ole2001{at}med.cornell.edu